Case series: Symptom‐inhibited fentanyl induction (SIFI) onto treatment‐dose opioid agonist therapy in a community setting
Safe transitions onto treatment-dose OAT are of heightened clinical importance at a time when fentanyl and high-potency synthetic opioids are now the norm. SIFI is a novel induction method that could address significant gaps in the currently available OAT options in the fentanyl era.
Authors
- Jéssica Lígia Picanço Machado (ORCID: https://orcid.org/0000-0003-0870-1090)
- Michael Krausz (ORCID: https://orcid.org/0000-0002-3509-7274)
- Martha J. Ignaszewski (ORCID: https://orcid.org/0000-0002-6887-1457)
- Pouya Azar (ORCID: https://orcid.org/0009-0009-8054-6911)
- James S.H. Wong (ORCID: https://orcid.org/0000-0003-3030-311X)
- Jane J. Kim (ORCID: https://orcid.org/0009-0006-7473-1617)
- Richard Davison
- Julio S. G. Montaner
- Andrew A. Herring
- Nickie Mathew
- Marianne Harris
- Zoran Barazanci
Institutions
- University of British Columbia (CA)
- Provincial Health Services Authority (CA)
- Alameda Health System (US)
- San Francisco Foundation (US)
- Vancouver General Hospital (CA)
- Public Health Institute (US)
- AIDS Vancouver (CA)
- Response Biomedical (Canada) (CA)
Publication Details
- Journal
- American Journal on Addictions
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1111/ajad.70011
- Citations
- 3
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.64